{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:05:54Z","timestamp":1793880354943,"version":"4.7.0"},"reference-count":37,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Anhui Province key research and development projects","award":["201904a07020099"],"award-info":[{"award-number":["201904a07020099"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmaceutical Biology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1080\/13880209.2021.1991386","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T12:22:43Z","timestamp":1635164563000},"page":"1439-1449","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Qingluoyin granules protect against adjuvant-induced arthritis in rats via downregulating the CXCL12\/CXCR4-NF-\u03baB signalling pathway"],"prefix":"10.1080","volume":"59","author":[{"given":"Min","family":"Si","sequence":"first","affiliation":[{"name":"Anhui Academy of Medical Sciences, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Ma","sequence":"additional","affiliation":[{"name":"Anhui Academy of Medical Sciences, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Anhui Academy of Medical Sciences, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Li","sequence":"additional","affiliation":[{"name":"Anhui Academy of Medical Sciences, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[{"name":"Anhui Academy of Medical Sciences, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[{"name":"Anhui Academy of Medical Sciences, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyu","family":"Jia","sequence":"additional","affiliation":[{"name":"Anhui Academy of Medical Sciences, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyong","family":"Luo","sequence":"additional","affiliation":[{"name":"Anhui Academy of Medical Sciences, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,10,25]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.6.3423"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep26239"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/13880209.2020.1844761"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-014-9887-0"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2018.1434793"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24844"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2006.04.006"},{"issue":"7","key":"e_1_3_2_9_1","first-page":"S128","article-title":"Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis","volume":"20","author":"Gibofsky A.","year":"2014","unstructured":"Gibofsky A. 2014. Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis. Am J Manag Care. 20(7 Suppl):S128\u2013S135.","journal-title":"Am J Manag Care"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1042\/bst025518s"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2018.11.009"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118261"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.269"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.9.5049"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200201)46:1<130::AID-ART10020>3.0.CO;2-D"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.86B2.14474"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells8020185"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2015.01.016"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1142\/S0192415X03001430"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1139\/bcb-2017-0074"},{"key":"e_1_3_2_21_1","first-page":"44","article-title":"Development of rheumatoid arthritis drugs in the world","volume":"34","author":"Liu LL","year":"2016","unstructured":"Liu LL, Mao YY, Gao LB. 2016. Development of rheumatoid arthritis drugs in the world. Sci Tech. Rev. 34:44\u201355.","journal-title":"Sci Tech. Rev"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2015.10.010"},{"key":"e_1_3_2_23_1","first-page":"1925","article-title":"Expression levels of CXCR4 and CXCL12 in patients with rheumatoid arthritis and its correlation with disease activity","volume":"20","author":"Peng L","year":"2020","unstructured":"Peng L, Zhu N, Mao J, Huang L, Yang Y, Zhou Z, Wang L, Wu B. 2020. Expression levels of CXCR4 and CXCL12 in patients with rheumatoid arthritis and its correlation with disease activity. Exp Ther Med. 20:1925\u20131934.","journal-title":"Exp Ther Med"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-020-00688-5"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.1"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30173-8"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2012.171"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2017.04.046"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2010.04293.x"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010920"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2016.11.011"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jnatprod.6b00554"},{"key":"e_1_3_2_33_1","unstructured":"Yang S. 2010. Qualitative and quantitative analysis of pharmacodynamic chemical and preliminary study of serum pharmacochemistry in Qing-Luo-Fang [Master\u2019s dissertation]. Beijing: Peking Union Medical College; p. 58\u201396."},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28253"},{"key":"e_1_3_2_35_1","first-page":"456747","article-title":"An integrative platform of TCM network pharmacology and its application on a herbal formula, Qing-Luo-Yin","volume":"2013","author":"Zhang B","year":"2013","unstructured":"Zhang B, Wang X, Li S. 2013. An integrative platform of TCM network pharmacology and its application on a herbal formula, Qing-Luo-Yin. Evid Based Complement Alternat Med. 2013:456747.","journal-title":"Evid Based Complement Alternat Med"},{"key":"e_1_3_2_36_1","unstructured":"Zhang K. 2015. Clinical study of QLY on the treatment of rheumatoid arthritis syndrome of dampness-heat syndrome [Master\u2019s dissertation]. Wuhu: Wannan Medical College; p. 15\u201329."},{"issue":"6","key":"e_1_3_2_37_1","first-page":"4831","article-title":"CP-25 exerts anti-angiogenic effects on a rat model of adjuvant-induced arthritis by promoting GRK2-induced downregulation of CXCR4-ERK1\/2 signaling in endothelial cells","volume":"20","author":"Zhang M","year":"2019","unstructured":"Zhang M, Gao M, Chen J, Song L, Wei W. 2019. CP-25 exerts anti-angiogenic effects on a rat model of adjuvant-induced arthritis by promoting GRK2-induced downregulation of CXCR4-ERK1\/2 signaling in endothelial cells. Mol Med Rep. 20(6):4831\u20134842.","journal-title":"Mol Med Rep"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01472"}],"container-title":["Pharmaceutical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13880209.2021.1991386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T16:21:49Z","timestamp":1711383709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13880209.2021.1991386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1080\/13880209.2021.1991386"],"URL":"https:\/\/doi.org\/10.1080\/13880209.2021.1991386","relation":{},"ISSN":["1388-0209","1744-5116"],"issn-type":[{"value":"1388-0209","type":"print"},{"value":"1744-5116","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iphb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iphb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-05-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}